CoChat

Treatment with a Copper-Zinc Chelator Markedly and Rapidly Inhibits β-Amyloid Accumulation in Alzheimer's Disease Transgenic Mice

Open access

The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.

Abstract

Inhibition of neocortical beta-amyloid (Abeta) accumulation may be essential in an effective therapeutic intervention for Alzheimer's disease (AD). Cu and Zn are enriched in Abeta deposits in AD, which are solubilized by Cu/Zn-selective chelators in vitro. Here we report a 49% decrease in brain Abeta deposition (-375 microg/g wet weight, p = 0.0001) in a blinded study of APP2576 transgenic mice treated orally for 9 weeks with clioquinol, an antibiotic and bioavailable Cu/Zn chelator. This was accompanied by a modest increase in soluble Abeta (1.45% of total cerebral Abeta); APP, synaptophysin, and GFAP levels were unaffected. General health and body weight parameters were significantly more stable in the treated animals. These results support targeting the interactions of Cu and Zn with Abeta as a novel therapy for the prevention and treatment of AD.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s0896-6273(01)00317-8

Cites

54 of 54 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

1 more claim about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 54 references

Research works printed but not linked: 4

  1. Bush, 1999, The possible origin of free radicals from amyloid β peptides in Alzheimer's disease, Neurobiol. Aging, 20, 335
  2. Clifford Rose, 1984, Clioquinol neurotoxicity, Acta Neurol. Scand. Suppl., 100, 137
  3. Shiraki, H. (1979). Handbook of Clinical Neurology, Vol. 37 (Amsterdam: Elsevier/North-Holland Biomedical Press).
  4. Tateishi, 1975, Experimental reproduction of SMON in animals by prolonged administration of clioquinol, Jpn. J. Med. Sci. Biol., 28, 165

Cited by

See all 1,447

Metadata

Authors
Cherny, R. A., Atwood, C. S., Xilinas, M. E., Gray, D. N., Jones, W. D., McLean, C. A., Barnham, K. J., Volitakis, I., Fraser, F. W., Kim, Y.-S., Huang, X., Goldstein, L. E., Moir, R. D., Lim, J. T., Beyreuther, K., Zheng, H., Tanzi, R. E., Masters, C. L., & Bush, A. I.
Affiliations
  • Mental Health Research Institute (AU)
  • Harvard University (US)
  • Sahlgrenska University Hospital (SE)
  • Heidelberg University (DE)
  • Baylor College of Medicine (US)
Corresponding author
Bush, Ashley I
Venue
Neuron
Publisher
Elsevier BV
Published
2001-05
Volume
30
Issue
3
Pages
665-676
ISSN
0896-6273 (ISSN-L)
OpenAlex
W2051516838
Cited by
1,447
References
54
Citations by year
2026: 15 · 2025: 36 · 2024: 38 · 2023: 39 · 2022: 39 · 2021: 36 · 2020: 51 · 2019: 41 · 2018: 44 · 2017: 45 · 2016: 40 · 2015: 60 · 2014: 53 · 2013: 49 · 2012: 77
FWCI
45.72
Type
journal article
Language
en
Open access
Licence
Locations
  • Neuron (publishedVersion)
  • PubMed (publishedVersion)
Funders
Medical Research Council
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Health Sciences › Medicine › Pharmacology (medical) › Cholinesterase and Neurodegenerative Diseases
Keywords
Alzheimer's disease, amyloid-beta deposition, clioquinol, neuroinflammation, synaptophysin, glial fibrillary acidic protein
MeSH terms
Age Factors, Alzheimer Disease, Animals, Chelating Agents, Copper, Female, Glial Fibrillary Acidic Protein, Clioquinol, Male, Mice, Inbred Strains, Mice, Transgenic, Zinc, Amyloid beta-Peptides, Synaptophysin, Mice, Plaque, Amyloid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Treatment with a Copper-Zinc Chelator Markedly and Rapidly Inhibits β-Amyloid Accumulation in Alzheimer's Disease Transgenic Mice. https://app.cochat.ai/papers/10.1016/s0896-6273(01)00317-8
The paper
Cherny, R. A., Atwood, C. S., Xilinas, M. E., Gray, D. N., Jones, W. D., McLean, C. A., Barnham, K. J., Volitakis, I., Fraser, F. W., Kim, Y.-S., Huang, X., Goldstein, L. E., Moir, R. D., Lim, J. T., Beyreuther, K., Zheng, H., Tanzi, R. E., Masters, C. L., & Bush, A. I. (2001). Treatment with a Copper-Zinc Chelator Markedly and Rapidly Inhibits β-Amyloid Accumulation in Alzheimer's Disease Transgenic Mice. Neuron. https://doi.org/10.1016/s0896-6273(01)00317-8

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.